Curative and palliative multimodal treatment concepts for soft tissue sarcomas

被引:0
作者
Lindner, L. H. [1 ,2 ]
机构
[1] LMU Klinikum, Med Klin & Poliklin 3, Marchioninistr 15, D-81377 Munich, Germany
[2] LMU Klinikum, Zentrum Knochen & Weichteiltumoren SarKUM, Munich, Germany
来源
ONKOLOGIE | 2023年 / 29卷 / 02期
关键词
Neoadjuvant chemotherapy; Local neoplasms recurrence; Hyperthermia; Radiation therapy; Immunotherapy; RANDOMIZED CLINICAL-TRIAL; ADJUVANT RADIATION-THERAPY; TERM-FOLLOW-UP; HIGH-RISK; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; HIGH-GRADE; OPEN-LABEL; MULTICENTER; PHASE-3;
D O I
10.1007/s00761-022-01288-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundPatients with locally advanced high-grade soft tissue sarcomas treated with tumor resection alone are at risk for both local recurrence and distant metastasis.ResultsThere are two phase III trials available for neoadjuvant chemotherapy. The ISG1001 trial showed that anthracycline-based chemotherapy is superior to histology-specific chemotherapy. The EORTC 62961/ESHO-RHT95 trial showed that the efficacy of anthracycline-based chemotherapy can be increased by adding regional deep hyperthermia. After both trials were conducted without a control arm using local therapy alone, the results of the retrospective analysis of the adjuvant EORTC 62931 trial are of particular importance. For patients with poor prognosis based on the Sarculator estimation, adjuvant anthracycline-based chemotherapy was associated with a significant survival benefit compared with local therapy alone. While the value of radiotherapy for high-grade extremity sarcomas is undoubted, the benefit of preoperative radiotherapy for retroperitoneal sarcomas has not been universally demonstrated.ConclusionsMultimodal therapy concepts that use chemotherapy, radiotherapy, and hyperthermia in addition to tumor resection improve the prognosis of patients with high-risk soft tissue sarcomas.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 42 条
[11]   Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group [J].
Gronchi, A. ;
Stacchiotti, S. ;
Verderio, P. ;
Ferrari, S. ;
Broto, J. Martin ;
Lopez-Pousa, A. ;
Llombart-Bosch, A. ;
Tos, A. P. Dei ;
Collini, P. ;
Cruz Jurado, J. ;
De Paoli, A. ;
Donati, D. M. ;
Poveda, A. ;
Quagliuolo, V. ;
Comandone, A. ;
Grignani, G. ;
Morosi, C. ;
Messina, A. ;
De Sanctis, R. ;
Bottelli, S. ;
Palassini, E. ;
Casali, P. G. ;
Picci, Piero .
ANNALS OF ONCOLOGY, 2016, 27 (12) :2283-2288
[12]  
Gronchi A, 2019, J CLIN ONCOL, V37
[13]   Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial [J].
Gronchi, Alessandro ;
Ferrari, Stefano ;
Quagliuolo, Vittorio ;
Martin-Broto, J. ;
Lopez Pousa, Antonio ;
Grignani, Giovanni ;
Basso, Umberto ;
Blay, Jean-Yves ;
Tendero, Oscar ;
Diaz Beveridge, Robert ;
Ferraresi, Virginia ;
Lugowska, Iwona ;
Merlo, Domenico Franco ;
Fontana, Valeria ;
Marchesi, Emanuela ;
Donati, Davide Maria ;
Palassini, Elena ;
Palmerini, Emanuela ;
De Sanctis, Rita ;
Morosi, Carlo ;
Stacchiotti, Silvia ;
Bague, Silvia ;
Coindre, Jean Michelle ;
Dei Tos, Angelo Paolo ;
Picci, Piero ;
Bruzzi, Paolo ;
Casali, Paolo Giovanni .
LANCET ONCOLOGY, 2017, 18 (06) :812-822
[14]   Short, Full-Dose Adjuvant Chemotherapy in High-Risk Adult Soft Tissue Sarcomas: A Randomized Clinical Trial From the Italian Sarcoma Group and the Spanish Sarcoma Group [J].
Gronchi, Alessandro ;
Frustaci, Sergio ;
Mercuri, Mario ;
Martin, Javier ;
Lopez-Pousa, Antonio ;
Verderio, Paolo ;
Mariani, Lidia ;
Valagussa, Pinuccia ;
Miceli, Rosalba ;
Stacchiotti, Silvia ;
Dei Tos, Angelo Paolo ;
De Paoli, Antonino ;
Longhi, Alessandra ;
Poveda, Andres ;
Quagliuolo, Vittorio ;
Comandone, Alessandro ;
Casali, Paolo Giovanni ;
Picci, Piero .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) :850-856
[15]   Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy [J].
Huang, Liping ;
Li, Yanan ;
Du, Yunai ;
Zhang, Yiyi ;
Wang, Xiuxia ;
Ding, Yuan ;
Yang, Xiangliang ;
Meng, Fanling ;
Tu, Jiasheng ;
Luo, Liang ;
Sun, Chunmeng .
NATURE COMMUNICATIONS, 2019, 10 (1)
[16]   Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: translation into clinical application [J].
Issels, Rolf ;
Kampmann, Eric ;
Kanaar, Roland ;
Lindner, Lars H. .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2016, 32 (01) :89-95
[17]   Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma The EORTC 62961-ESHO 95 Randomized Clinical Trial [J].
Issels, Rolf D. ;
Lindner, Lars H. ;
Verweij, Jaap ;
Wessalowski, Rudiger ;
Reichardt, Peter ;
Wust, Peter ;
Ghadjar, Pirus ;
Hohenberger, Peter ;
Angele, Martin ;
Salat, Christoph ;
Vujaskovic, Zeljko ;
Daugaard, Soeren ;
Mella, Olav ;
Mansmann, Ulrich ;
Durr, Hans Roland ;
Knosel, Thomas ;
Abdel-Rahman, Sultan ;
Schmidt, Michael ;
Hiddemann, Wolfgang ;
Jauch, Karl-Walter ;
Belka, Claus ;
Gronchi, Alessandro .
JAMA ONCOLOGY, 2018, 4 (04) :483-492
[18]   Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study [J].
Issels, Rolf D. ;
Lindner, Lars H. ;
Verweij, Jaap ;
Wust, Peter ;
Reichardt, Peter ;
Schem, Baard-Christian ;
Abdel-Rahman, Sultan ;
Daugaard, Soeren ;
Salat, Christoph ;
Wendtner, Clemens-Martin ;
Vujaskovic, Zeljko ;
Wessalowski, Ruediger ;
Jauch, Karl-Walter ;
Duerr, Hans Roland ;
Ploner, Ferdinand ;
Baur-Melnyk, Andrea ;
Mansmann, Ulrich ;
Hiddemann, Wolfgang ;
Blay, Jean-Yves ;
Hohenberger, Peter .
LANCET ONCOLOGY, 2010, 11 (06) :561-570
[19]   Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database [J].
Italiano, A. ;
Delva, F. ;
Mathoulin-Pelissier, S. ;
Le Cesne, A. ;
Bonvalot, S. ;
Terrier, P. ;
Trassard, M. ;
Michels, J. -J. ;
Blay, J. -Y. ;
Coindre, J. -M. ;
Bui, B. .
ANNALS OF ONCOLOGY, 2010, 21 (12) :2436-2441
[20]   Prognostic Factors and Impact of Adjuvant Treatments on Local and Metastatic Relapse of Soft-Tissue Sarcoma Patients in the Competing Risks Setting [J].
Italiano, Antoine ;
Le Cesne, Axel ;
Mendiboure, Jean ;
Blay, Jean-Yves ;
Piperno-Neumann, Sophie ;
Chevreau, Christine ;
Delcambre, Corinne ;
Penel, Nicolas ;
Terrier, Philippe ;
Ranchere-Vince, Dominique ;
Lae, Marick ;
Le Guellec, Sophie ;
Michels, Jean-Jacques ;
Robin, Yves Marie ;
Bellera, Carine ;
Bonvalot, Sylvie .
CANCER, 2014, 120 (21) :3361-3369